Why the study?
Cardiovascular disease is the leading cause of death in women yet remains underdiagnosed, undertreated, and portends worse outcomes compared with men, with persistent disparities across cardiovascular science.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
CVD disparities in women warrant clinical vigilance to improve outcomes; leaves open effective strategies across research, management, and leadership.
Cardiovascular disease is the leading cause of death in women. It remains underdiagnosed, undertreated, and portends worse outcomes in women than men. Disparities exist in every stage of science, from bench research to the editorial board of major journals and in every cardiovascular subspecialty. This review summarizes differences in cardiovascular risk factors and disparities in management and outcomes of ischemic heart disease, heart failure, aortic stenosis, and atrial fibrillation. It also provides an overview of female representation as participants and leaders of clinical trials, editorial boards, and academic institutions. Strategies to overcome these disparities are proposed with examples of successful programs.
No takes yet. Share an insight, caveat, or question.
Mahowald et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: